Abbott Spine, Inc., a leading name in the spinal implant industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in the early 2000s, the company has established itself as a pioneer in developing innovative spinal solutions, focusing on enhancing patient outcomes and surgical efficiency. Specialising in advanced spinal implants and surgical instruments, Abbott Spine is recognised for its commitment to quality and innovation. Their core products include a range of fusion devices and minimally invasive surgical tools, designed to meet the evolving needs of healthcare professionals. With a strong market position, Abbott Spine has achieved notable milestones, including several patents for groundbreaking technologies that set them apart in the competitive landscape of spinal care.
How does Abbott Spine, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Abbott Spine, Inc.'s score of 43 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Abbott Spine, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is part of a corporate family that includes Zimmer Biomet Holdings, Inc., from which it inherits climate commitments and performance metrics. As a merged entity, Abbott Spine, Inc. aligns its climate initiatives with those of Zimmer Biomet, which has established science-based targets for emissions reduction. However, specific reduction targets or achievements for Abbott Spine, Inc. have not been disclosed. The lack of direct emissions data suggests that Abbott Spine, Inc. is in the early stages of formalising its climate commitments. The company may benefit from the broader sustainability strategies and initiatives of Zimmer Biomet, which include participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). Overall, while Abbott Spine, Inc. has not yet published its own emissions data or reduction targets, its affiliation with Zimmer Biomet Holdings, Inc. positions it within a framework of corporate responsibility and climate action.
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | 00,000,000 | 
| Scope 2 | - | - | - | - | - | - | - | 00,000,000 | 
| Scope 3 | - | - | - | - | - | - | - | - | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Abbott Spine, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.